425 related articles for article (PubMed ID: 7395618)
1. A comparative study of bromocriptine and levodopa in Parkinson's disease.
Duvoisin RC; Mendoza MM; Yahr MD
Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
[No Abstract] [Full Text] [Related]
2. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Gawel M; Riopelle R; Libman I; Bouchard S
Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
[No Abstract] [Full Text] [Related]
3. The role of bromocriptine in the treatment of Parkinson's disease.
Stern GM; Lees AJ; Shaw KM; Lander CM
Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
[No Abstract] [Full Text] [Related]
4. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Meco G; Casacchia M; Zamponi A; Agnoli A
Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
[No Abstract] [Full Text] [Related]
5. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
[TBL] [Abstract][Full Text] [Related]
6. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
Hauser RA; Holford NH
Mov Disord; 2002 Sep; 17(5):961-8. PubMed ID: 12360545
[TBL] [Abstract][Full Text] [Related]
7. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
Fischer PA; Przuntek H; Majer M; Welzel D
Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
[TBL] [Abstract][Full Text] [Related]
8. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
9. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Factor SA; Weiner WJ
Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289
[TBL] [Abstract][Full Text] [Related]
10. Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy.
Stern MB; Vernon GM; Gollomp SM; Hurtig HI
Bull Clin Neurosci; 1986; 51():52-6. PubMed ID: 3455244
[TBL] [Abstract][Full Text] [Related]
11. Further experiences with low doses of bromocriptine in Parkinson's disease.
Fahn S; Côté LJ; Barrett RE; Snider SR
Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
[No Abstract] [Full Text] [Related]
12. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
13. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
Godwin-Austen RB
Adv Biochem Psychopharmacol; 1980; 23():261-5. PubMed ID: 7395616
[No Abstract] [Full Text] [Related]
14. Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
van der Drift JH
Adv Neurol; 1987; 45():529-34. PubMed ID: 3825731
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
Dufresne JJ
Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
[No Abstract] [Full Text] [Related]
16. The Sydney multicentre study of Parkinson's disease. The first 18 months.
Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy: problems and practices.
Muenter MD
Clin Neuropharmacol; 1986; 9 Suppl 1():S23-36. PubMed ID: 3708606
[TBL] [Abstract][Full Text] [Related]
18. [Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years].
Montastruc JL; Rascol O; Rascol A
Therapie; 1988; 43(6):461-3. PubMed ID: 3227512
[No Abstract] [Full Text] [Related]
19. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
Todman DH; Oliver WA; Edwards RL
Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
[TBL] [Abstract][Full Text] [Related]
20. The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Olanow CW; Hauser RA; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
Ann Neurol; 1995 Nov; 38(5):771-7. PubMed ID: 7486869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
